Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua Millstein

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
The Lancet. Child & Adolescent Health|February 14, 2021
Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort studyDiana J Moke, Chunqiao Luo, Joshua Millstein, et al.
Oncogene|July 4, 2025
Pan-RAS inhibitors and polo-like kinase 1: promising targets in colorectal cancerPriya Jayachandran, Andrew Elliott, Shivani Soni, et al.
Clinical Colorectal Cancer|October 9, 2018
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based ChemotherapyRyuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Scientific Reports|June 10, 2021
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patientsMadiha Naseem, Shu Cao, Dongyun Yang, et al.
Oncogene|October 1, 2022
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatmentFrancesca Battaglin, Priya Jayachandran, Carly Strelez, et al.
The Journal of Infectious Diseases|December 6, 2019
Association of HLA Genotype With T-Cell Activation in Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus-Coinfected WomenAndrea A Z Kovacs, Naoko Kono, Chia-Hao Wang, et al.
International Journal of Molecular Sciences|March 27, 2025
Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal CancerPooja Mittal, Francesca Battaglin, Yan Yang, et al.
Journal for Immunotherapy of Cancer|November 11, 2020
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancerHiroyuki Arai, Yi Xiao, Fotios Loupakis, et al.
Molecular Cancer Therapeutics|March 31, 2021
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICCHiroyuki Arai, Shu Cao, Francesca Battaglin, et al.
ACS Nano|March 29, 2018
Single-Cell Digital Lysates Generated by Phase-Switch Microfluidic Device Reveal Transcriptome Perturbation of Cell CycleYan Chen, Joshua Millstein, Yao Liu, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
The Lancet. Child & Adolescent Health|February 14, 2021
Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort studyDiana J Moke, Chunqiao Luo, Joshua Millstein, et al.
Oncogene|July 4, 2025
Pan-RAS inhibitors and polo-like kinase 1: promising targets in colorectal cancerPriya Jayachandran, Andrew Elliott, Shivani Soni, et al.
Clinical Colorectal Cancer|October 9, 2018
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based ChemotherapyRyuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Scientific Reports|June 10, 2021
Random survival forests identify pathways with polymorphisms predictive of survival in KRAS mutant and KRAS wild-type metastatic colorectal cancer patientsMadiha Naseem, Shu Cao, Dongyun Yang, et al.
Oncogene|October 1, 2022
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatmentFrancesca Battaglin, Priya Jayachandran, Carly Strelez, et al.
The Journal of Infectious Diseases|December 6, 2019
Association of HLA Genotype With T-Cell Activation in Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus-Coinfected WomenAndrea A Z Kovacs, Naoko Kono, Chia-Hao Wang, et al.
International Journal of Molecular Sciences|March 27, 2025
Genetic Polymorphisms in MHC Classes I and II Predict Outcomes in Metastatic Colorectal CancerPooja Mittal, Francesca Battaglin, Yan Yang, et al.
Journal for Immunotherapy of Cancer|November 11, 2020
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancerHiroyuki Arai, Yi Xiao, Fotios Loupakis, et al.
Molecular Cancer Therapeutics|March 31, 2021
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICCHiroyuki Arai, Shu Cao, Francesca Battaglin, et al.
ACS Nano|March 29, 2018
Single-Cell Digital Lysates Generated by Phase-Switch Microfluidic Device Reveal Transcriptome Perturbation of Cell CycleYan Chen, Joshua Millstein, Yao Liu, et al.
Pageof 9